Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|January 22, 2011
Blood coagulation factor Xa as an emerging drug targetKeren Borensztajn, C Arnold SpekCurrent Opinion in Pulmonary Medicine|March 9, 2018
Genetic causes and clinical management of pediatric interstitial lung diseasesNadia Nathan, Keren Borensztajn, Annick ClementRespiration; International Review of Thoracic Diseases|December 21, 2013
Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench sideKeren Borensztajn, Bruno Crestani, Martin KolbThrombosis Research|March 30, 2010
Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivationKeren Borensztajn, Maikel P Peppelenbosch, C Arnold SpekExpert Review of Respiratory Medicine|October 23, 2018
Chronic interstitial lung diseases in children: diagnosis approachesNadia Nathan, Laura Berdah, Keren Borensztajn, et al.Trends in Molecular Medicine|September 9, 2008
Factor Xa: at the crossroads between coagulation and signaling in physiology and diseaseKeren Borensztajn, Maikel P Peppelenbosch, C Arnold SpekTrends in Pharmacological Sciences|December 9, 2008
Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?Keren Borensztajn, Maikel P Peppelenbosch, C Arnold SpekBiochimica Et Biophysica Acta|April 3, 2009
FXa-induced intracellular signaling links coagulation to neoangiogenesis: potential implications for fibrosisKeren Borensztajn, Hella Aberson, Maikel P Peppelenbosch, et al.Journal of Cellular and Molecular Medicine|December 9, 2009
The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigmKeren Borensztajn, Jan H von der Thüsen, Maikel P Peppelenbosch, et al.Thrombosis Research|March 3, 2009
Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activationKeren Borensztajn, Maarten F Bijlsma, Pieter H Reitsma, et al.Pageof 3